Amniotic Membrane Therapy for Interstitial Cystitis/Painful Bladder Syndrome
This study is testing a treatment called Clarix Flo, which uses micronized amniotic membrane, for people with Interstitial Cystitis/Painful Bladder Syndrome (IC/PBS). IC/PBS causes bladder and pelvic pain, pressure, and frequent or urgent urination. Researchers want to see if Clarix Flo can improve these symptoms. You might be able to join if you are a woman, 18 or older, speak English, have been diagnosed with IC/PBS, and have already tried at least one other treatment that didn't work. The study will measure success by looking at changes in your symptom scores over 12 weeks. The current status of this study is unclear, but it plans to enroll 100 participants.
- Study design
- This study is an interventional trial, meaning participants will receive a specific treatment. It plans to enroll 100 participants.
- What's involved
- Not specified in the trial record.
- Compensation
- Not stated in the trial record.
- Follow-up
- Participants will be followed for 12 weeks after treatment.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Amniotic Membrane Therapy for Interstitial Cystitis/Painful Bladder Syndrome
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- David Sheyn, MD · PRINCIPAL_INVESTIGATOR · University Hospitals Cleveland Medical Center
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Change in Interstitial Cystitis Symptom Index (ICSI) scoreTo be completed pre-operatively and at 2, 4, 8 and 12 weeks post-operatively
Evaluate for clinically-meaningful reduction in symptoms as defined as a 5 point reduction in Interstitial Cystitis Symptom Index (ICSI)